Overview

Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)

Status:
Unknown status

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the effect of (NAC) N-Acetyl Cysteine on biomarkers of Delayed Graft Function (DGF), including Neutrophil Gelatinase Associated Lipocalin (NGAL) and Intereleukin 18 (IL18).

Phase:

Phase 3

Details

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Treatments:

Acetylcysteine
N-monoacetylcystine